Open Access
Retraction: miR-211 suppresses hepatocellular carcinoma by downregulating SATB2
Oncotarget · 06.01.2026 · 17 (1) · 199-200
DOI: 10.18632/oncotarget.28837 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncotarget, erschienen am 06.01.2026. Verfasst von Guixing Jiang und 5 weiteren Autor:innen. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Jiang, G., Cui, Y., Yu, X., Wu, Z., Ding, G., & Cao, L. (2026). Retraction: miR-211 suppresses hepatocellular carcinoma by downregulating SATB2. Oncotarget, 17(1), 199-200. https://doi.org/10.18632/oncotarget.28837
Vancouver
Jiang G, Cui Y, Yu X, Wu Z, Ding G, Cao L. Retraction: miR-211 suppresses hepatocellular carcinoma by downregulating SATB2. Oncotarget. 2026;17(1):199-200. doi:10.18632/oncotarget.28837
BibTeX
@article{Jiang2026,
author = {Jiang, Guixing and Cui, Yunfu and Yu, Xin and Wu, Zhengrong and Ding, Guoping and Cao, Liping},
title = {Retraction: miR-211 suppresses hepatocellular carcinoma by downregulating SATB2},
journal = {Oncotarget},
year = {2026},
volume = {17},
number = {1},
pages = {199--200},
doi = {10.18632/oncotarget.28837}
}
EUVIMED